BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17355906)

  • 1. Biological roles of anti-GM1 antibodies in patients with Guillain-Barré syndrome for nerve growth factor signaling.
    Tanaka T; Furutama D; Sakai R; Fujita A; Kimura F; Tagami M; Ohsawa N; Hanafusa T
    Biochim Biophys Acta; 2007 May; 1772(5):543-8. PubMed ID: 17355906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-GM1 antibodies affect the integrity of lipid rafts.
    Ueda A; Shima S; Miyashita T; Ito S; Ueda M; Kusunoki S; Asakura K; Mutoh T
    Mol Cell Neurosci; 2010 Dec; 45(4):355-62. PubMed ID: 20659560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpressed GM1 suppresses nerve growth factor (NGF) signals by modulating the intracellular localization of NGF receptors and membrane fluidity in PC12 cells.
    Nishio M; Fukumoto S; Furukawa K; Ichimura A; Miyazaki H; Kusunoki S; Urano T; Furukawa K
    J Biol Chem; 2004 Aug; 279(32):33368-78. PubMed ID: 15145933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local anesthetics suppress nerve growth factor-mediated neurite outgrowth by inhibition of tyrosine kinase activity of TrkA.
    Takatori M; Kuroda Y; Hirose M
    Anesth Analg; 2006 Feb; 102(2):462-7. PubMed ID: 16428543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-GM1 ganglioside antibodies modulate membrane-associated sphingomyelin metabolism by altering neutral sphingomyelinase activity.
    Ueda A; Shima S; Murate K; Kikuchi K; Nagao R; Maeda T; Muto E; Niimi Y; Mizutani Y; Mutoh T
    Mol Cell Neurosci; 2018 Jun; 89():42-48. PubMed ID: 29601870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ganglioside GM1 binding toxins and human neuropathy-associated IgM antibodies differentially promote neuritogenesis in a PC12 assay.
    O'Hanlon GM; Hirst TR; Willison HJ
    Neurosci Res; 2003 Dec; 47(4):383-90. PubMed ID: 14630342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of immunoglobulin G antibodies in Guillain-Barré syndrome sera to a mixture of GM1 and a phospholipid: possible clinical implications.
    Kusunoki S; Morita D; Ohminami S; Hitoshi S; Kanazawa I
    Muscle Nerve; 2003 Mar; 27(3):302-6. PubMed ID: 12635116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An antibody to the GM1/GalNAc-GD1a complex correlates with development of pure motor Guillain-Barré syndrome with reversible conduction failure.
    Ogawa G; Kaida K; Kuwahara M; Kimura F; Kamakura K; Kusunoki S
    J Neuroimmunol; 2013 Jan; 254(1-2):141-5. PubMed ID: 23000056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chloride channel 4 is required for nerve growth factor-induced TrkA signaling and neurite outgrowth in PC12 cells and cortical neurons.
    Hur J; Jeong HJ; Park J; Jeon S
    Neuroscience; 2013 Dec; 253():389-97. PubMed ID: 24036377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of laminin-1 to monosialoganglioside GM1 in lipid rafts is crucial for neurite outgrowth.
    Ichikawa N; Iwabuchi K; Kurihara H; Ishii K; Kobayashi T; Sasaki T; Hattori N; Mizuno Y; Hozumi K; Yamada Y; Arikawa-Hirasawa E
    J Cell Sci; 2009 Jan; 122(Pt 2):289-99. PubMed ID: 19118221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GM1/GalNAc-GD1a complex: a target for pure motor Guillain-Barre syndrome.
    Kaida K; Sonoo M; Ogawa G; Kamakura K; Ueda-Sada M; Arita M; Motoyoshi K; Kusunoki S
    Neurology; 2008 Nov; 71(21):1683-90. PubMed ID: 19015484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
    Gregson NA; Koblar S; Hughes RA
    Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Abl tyrosine kinase enhances nerve growth factor-mediated signaling in Bcr-Abl transformed cells via the alteration of signaling complex and the receptor turnover.
    Koch A; Scherr M; Breyer B; Mancini A; Kardinal C; Battmer K; Eder M; Tamura T
    Oncogene; 2008 Aug; 27(34):4678-89. PubMed ID: 18427551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential endocytic trafficking of neuropathy-associated antibodies to GM1 ganglioside and cholera toxin in epithelial and neural cells.
    Iglesias-Bartolomé R; Trenchi A; Comín R; Moyano AL; Nores GA; Daniotti JL
    Biochim Biophys Acta; 2009 Dec; 1788(12):2526-40. PubMed ID: 19800863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinction between differentiation, cell cycle, and apoptosis signals in PC12 cells by the nerve growth factor mutant delta9/13, which is selective for the p75 neurotrophin receptor.
    Hughes AL; Messineo-Jones D; Lad SP; Neet KE
    J Neurosci Res; 2001 Jan; 63(1):10-9. PubMed ID: 11169609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve growth factor-induced neurite outgrowth is potentiated by stabilization of TrkA receptors.
    Song EJ; Yoo YS
    BMB Rep; 2011 Mar; 44(3):182-6. PubMed ID: 21429296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-GM1 IgG antibodies and Campylobacter bacteria in Guillain-Barré syndrome: evidence of molecular mimicry.
    Oomes PG; Jacobs BC; Hazenberg MP; Bänffer JR; van der Meché FG
    Ann Neurol; 1995 Aug; 38(2):170-5. PubMed ID: 7654064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome.
    Yuki N; Susuki K; Koga M; Nishimoto Y; Odaka M; Hirata K; Taguchi K; Miyatake T; Furukawa K; Kobata T; Yamada M
    Proc Natl Acad Sci U S A; 2004 Aug; 101(31):11404-9. PubMed ID: 15277677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Domain-dependent modulation of PDGFRbeta by ganglioside GM1.
    Oblinger JL; Boardman CL; Yates AJ; Burry RW
    J Mol Neurosci; 2003 Apr; 20(2):103-14. PubMed ID: 12794304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.